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Highlights
 We developed a sample clean-up method to detect tuberculosis from sputum by GC-MS.
 Biomarkers recovered: 64-70% (standards solution), and 36-68% (sputum extracts).
 Cholesterol removed: 93-98% (standards solution) and 62-92% (sputum extracts).
 Less cholesterol in the filtered extracts avoids overloading of the analytical system.
 Analysing large sample batches will need fewer interruptions for system cleaning.
ABSTRACT
A proof of principle gas chromatography-mass spectrometry method is presented, in 
combination with clean up assays, aiming to improve the analysis of methyl mycocerosate 
tuberculosis biomarkers from sputum. Methyl mycocerosates are generated from the 
transesterification of phthiocerol dimycocerosates (PDIMs), extracted in petroleum ether from 
sputum of tuberculosis suspect patients. When a high matrix background is present in the 
sputum extracts, the identification of the chromatographic peaks corresponding to the methyl 
derivatives of PDIMs analytes may be hindered by the closely eluting methyl ether of 
cholesterol, usually an abundant matrix constituent frequently present in sputum samples.
The purification procedures involving solid phase extraction (SPE) based methods with both 
commercial Isolute-Florisil cartridges, and purpose designed molecularly imprinted polymeric 
materials (MIPs), resulted in cleaner chromatograms, while the mycocerosates are still 
present. The clean-up performed on solutions of PDIMs and cholesterol standards in 
petroleum ether show that, depending on the solvent mix and on the type of SPE used, the 
recovery of PDIMs is between 64 – 70 %, whilst most of the cholesterol is removed from the 
system. When applied to petroleum ether extracts from representative sputum samples, the 
clean-up procedures resulted in recoveries of 36 - 68 % for PDIMs, allowing some superior 
detection of the target analytes.
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INTRODUCTION
Tuberculosis (TB) is an infectious disease that is still of increasing concern, with higher 
incidence in the underdeveloped countries, it represents a world scale problem, given the 
extensive international mobility of people in the 21st century [1], and its early diagnosis is 
crucial in reducing and stopping the disease from spreading [2]. The cell envelopes of 
Mycobacterium tuberculosis are rich in unusual lipids, not present in the mammalian tissue. 
These compounds are therefore considered as proper mycobacterial biomarkers that can 
enable the disease detection in fluids from infected patients. 
Gas chromatographic-mass spectrometric (GC-MS) analysis, following the offline or online 
derivatization of lipids from the mycobacterial cell membrane, has been proven to be 
successful for the TB diagnosis by detecting M. tuberculosis biomarkers in sputum [3-7]. The 
10-methyl octadecanoic acid biomarker, also known as tuberculostearic acid (TBSA), has 
been frequently analyzed by GC-MS in positive [3-6] and negative chemical ionisation (NCI) 
modes [7], but it is almost ubiquitous among the members of mycolata class, and in other 
genera such as Nocardia. Furthermore, TBSA is dispersed in the cell envelope within a 
range of plasma membrane phospholipids and lipoglycans, and access to the full content of 
TBSA requires its prior hydrolytic release by complicated chemical manipulations [3,4,6,7]. 
Direct analysis of TBSA by GC-MS was reported [5], following thermochemolysis of aliquots 
from sputum samples, but our experiments based on this procedure [8] resulted in poor 
sensitivity and specificity, owing to the TBSA ester co-elution with derivatives of other matrix 
compounds, such as the methyl ester of octadecanoic acid, which is usually present in 
excessive amounts in sputum.
There are other classes of lipids which can be immediately accessible for rapid analysis, 
using simple solvent extraction from culture or sputum sample deposits. Our study involves 
the more accessible class, the family of phthiocerol dimycocerosates (PDIMs) shown in 
Figure 1. They are stable, high molecular weight hydrophobic waxes of around a 90 carbon
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backbone, which are highly resistant to hydrolysis, and hence will survive the usual 
procedures used to sterilise infected materials isolated from patients. The mycocerosate 
components are only present in a limited number of mycobacteria (Mycobacterium microti, 
Mycobacterium bovis, Mycobacterium kansasii, Mycobacterium marinum, Mycobacterium 
ulcerans and Mycobacterium leprae) [9-12]. The methyl derivatives of mycocerosates from 
M. tuberculosis give characteristic doublet peaks with dominant C29, C30, and C32
components. In an early study by Larsson, five-days-old cultures of sputum specimens were 
shown by GC-MS to have C32 mycocerosates [6]. Negative-ion chemical ionisation GC-MS 
methods developed for sensitive detection of mycobacterial mycocerosates [9], has been 
used to detect mycocerosate biomarkers for ancient tuberculosis in a skeletal collection [13].
Our work focuses on PDIMs as excellent M. tuberculosis biomarkers. Following apolar lipid 
extraction from sputum, PDIMs were submitted to thermally assisted hydrolysis and 
methylation (THM) in the programmed temperature vaporizer (PTV) inlet, and the resulting 
methyl mycocerosates, shown in Figure 2, were then analysed by GC-MS. The initial THM-
GC-MS method development [14] and its application to a batch of positive and negative real 
sputum samples [15] were presented in our earlier publications, which focused on the overall 
method performance without reporting and discussing the particular results obtained in 
certain sputum sample extracts with a high level of matrix compounds. Blind analysis of the 
PE extracts of 400+ sputum specimens [15], using our THM-GC-MS method gave 64.9 % 
sensitivity and 76.2 % specificity, and it was noted that other components of sputum, such as 
cholesterol, may hinder the analysis. The presence of matrix peaks in the retention time 
region of the analytes and a high baseline rendered difficult the assignment of the target 
doublet peaks, when a low target signal was hidden by abundant background peaks.
Derivatized matrix compounds build up in the inlet, which eventually leads to active sites and 
may compromise subsequent runs. This also impacted on the column life time, causing 
frequent column overloading and even column blockages, the capillary column needed 
trimming and/or replacement. Both the PTV inlet and the EIMS ionisation source required 
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cleaning on a regular basis, which is not ideal for a routine method. It is therefore desirable to 
extract PDIMs from the sputum sample, and to filter the extract in order to purify and 
concentrate them prior to analysis.
In the present work, a proof of principle clean up method was developed, aiming for a 
maximum recovery of PDIMs and minimum collection of cholesterol from a stock solution of 
PDIMs and cholesterol standards in PE. The lipid extraction from sputum samples was 
performed with a combination of apolar petroleum ether (PE) and an immiscible polar solvent 
(methanol), applying a modified Dobson protocol [10]. Four PE extracts of positive sputum 
samples were selected that were previously [15] found to have high amounts of cholesterol. 
These were then passed through different solid phase extraction (SPE) materials, both 
commercial and molecularly imprinted polymers (MIPs) cartridges. Molecular imprinting is 
performed by producing a polymeric matrix, containing complementary residues, in the 
presence of the target molecule [16], in this case cholesterol. After formation, the original 
template is removed, leaving cavities that are complementary to the shape and chemical 
profile of the template, only allowing specific recognition and rebinding. 
1. EXPERIMENTAL
2.1 Molecularly imprinted polymer synthesis
Methacrylic acid (MAA), ethyleneglycol dimethacrylate (EGDMA) and azo-N,N,′-
diisobutyronitrile (AIBN); and all solvents (HPLC grade) were purchased from Sigma Aldrich, 
(Dorset, UK).
Cholesterol is a favoured template for imprinting studies and has been imprinted by several 
different researchers [17, 18, 19]. A generic MAA/EGDMA methodology was used as proof-
of-principle, similar to that of Puoci [17]. For the polymerisation procedure, the template 
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(cholesterol), the monomers, cross-linker and free-radical initiator AIBN were dissolved in the 
porogen chloroform in the ratio 1:4:20 with 125 % of mixture to porogen ratio. An amount of 
25 mg of template was dissolved into 1.41 mL of chloroform in a 4.5 mL glass vial. To this 
solution, 21.9 μL of methacrylic acid (monomer) and 1.63 mL of EGDMA (cross-linker) were
added and mixed using a vortex. 10 mg of AIBN were added to this solution and mixed via 
vortex. Once all components had dissolved, the solution was then sparged with nitrogen for 1 
minute and the vial sealed. Polymerisation was carried out at 60 oC for 24 hours, in a dry 
oven. After polymerisation, the tubes were then smashed and the monolithic polymer 
obtained was ground with a mortar and pestle and wet-sieved (methanol) through a series of 
mesh metal sieve. Particle fractions of 63–38 μm size were collected. Fine particles were 
removed by repeated sedimentation using acetonitrile. Removal of the imprinted cholesterol 
from the imprinted particles was undertaken by a Soxhlet extraction with methanol–acetic 
acid (9:1, v/v) for 48 hours. Non-imprinted polymers (NIPs) were synthesized and treated 
simultaneously under the same conditions without the addition of the template. Empty 3 mL 
polymeric SPE cartridges were packed with 20 mg of polymer, between two glass fibre frits 
(20 µm porosity). This general method is adapted from Zulfiqar et al. [20].
2.2 Phthiocerol dimycocerosates (PDIMs) standard
The PDIMs standard consists of waxes extracted from freeze-dried M. tuberculosis strain C 
[21], using petroleum ether (PE) from Fischer Scientific (Loughborough, UK) in a biphasic 
mixture with aqueous methanol [10]. The main component of the PDIMs based on 
phthiocerol A [22], was purified from the PE extract by preparative thin-layer chromatography 
[23]. The relative abundances of the C29/C30 and C32 in the standard are not known, hence the 
quantitative analyses in this study will be reported with respect to the total amount of PDIMs 
present. Using petroleum ether (PE) (60 oC - 80 oC, pesticide residue grade, Distol) from 
Fisher Scientific (Loughborough, UK) as a solvent, a stock solution was prepared, containing 
625 ng.mL-1 of cholesterol (Acros) from Sigma-Aldrich (Gillingham, UK) and 17.2 ng.mL-1 of 
PDIMs standard.
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2.3 Sputum samples
Sputum specimens were collected from TB patients and suspects at Beatrice Road 
Infectious Diseases Hospital in Harare, Zimbabwe [24]. Sputum samples were homogenized 
with glass beads and then split into two: one sample was used for smear microscopy and 
culture. The second aliquot of sputum was frozen until shipment to London, where they were 
decontaminated and fully homogenized, using the modified Petroff’s method [25]. In brief, 0.5 
mL of the sputum samples were homogenized with 0.5 mL of 4 % methanolic NaOH, 
vortexed, incubated at room temperature for 20 min, then neutralized with phosphate buffer, 
washed in sterile distilled water, and centrifuged, resulting in a 1 mL initial sputum deposit 
that was heat killed (30 min at 100 oC), then stored at -80 oC prior to the apolar lipids 
extraction. Defrosted deposits were further concentrated by centrifugation at 14000 g for 15 
min. The supernatant (800 µL) was discarded leaving behind a 0.2 mL deposit that was 
subsequently submitted to the apolar lipid extraction.
1.4 Apolar lipid extraction
Using a modified method from Dobson [10], the apolar lipids were extracted from 0.2 mL of 
sputum deposits, by adding 1.8 mL methanol and 1 mL petroleum ether (60 – 80 oC), mixed 
on a tube rotator for 15 min, then centrifuged at 1200 g for 1 min. The upper PE layer, 
containing the apolar lipids, was removed and stored at 4 oC prior to the THM-GC-MS 
analysis.
1.5 Sample clean up
Firstly, aliquots of 50 µL of the stock solution of PDIMs and cholesterol standards mix in PE
were placed into different commercial SPE cartridges Isolute-Florisil from Biotage UK
(Hengoed, UK), then washed in 4 mL of the solvent mixtures (A) or (B) described below. In 
order to identify the solvent mix with the optimum polarity to wash out the pthiocerol 
dimycocerosates, while leaving the cholesterol adsorbed on the SPE cartridge, the following 
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solvent combinations were used: (A) dichloromethane and hexane (DCM+H), and (B) 
heptane with toluene (Hp+T) with the relative concentrations as summarised in Table 1. All 
the solvents were pesticide residue grade, Distol from Fisher Scientific (Loughborough, UK). 
Finally, the 4 mL of solvents mix eluted through the SPE cartridges were reconstituted in 50 
µL petroleum ether, and were then submitted to the THM-GC-MS analysis. Two positive 
sputum specimens were identified that had large cholesterol peaks in the original PE 
extracts. Aliquots of 50 µL from these PE extracts were loaded onto the SPE cartridges, and 
then the solvent mix that had been selected for the standards clean-up was further tested on 
the PE sputum extracts selected.
Secondly, 500 µL aliquots of the stock solution of PDIMs and cholesterol standards in PE 
were washed through molecular imprinted polymers (MIPs) SPE cartridges developed at The 
Open University, and 50 µL of the first eluent collected (roughly 350µL) were submitted to the 
THM-GC-MS analysis. The clean-up method was then tested on two other positive sputum 
samples, by filtering 500 µL of each PE sputum extract through a MIPs cartridge.
2.6 Equipment
An Agilent GC-MS system was used, consisting of a 7890A gas chromatograph equipped 
with a DB-5 MS capillary column (15 m x 0.25 mm x 0.25 µm) coupled to a 5975C 
quadrupole mass spectrometer (MS), with the electron impact (EI) ionization source set at 70 
eV and 35 µA emission current. The column dimensions in our method were consistent with 
the end-user operational requirements for its potential use as a diagnostic test in the field. An 
autosampler PAL-CTC provided with a LINEX liner exchanger was used in conjunction with 
an Optic3 programmable temperature vaporization (PTV) inlet, to perform the online 
derivatization of the analytes. Both the autosampler and the inlet were provided by GL-
Scientific (former ATAS-GL International) (Eindhoven, The Netherlands).
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2.7 Thermochemolysis
Fifty microlitre aliquots (i) of the initial stock solution of cholesterol (625 ng.mL-1) and PDIMs 
(17.2 ng.mL-1) in PE solvent; (ii) of the unfiltered PE sputum extracts; and (iii) of each eluent 
through the SPE cartridges were manually applied to a quartz wool plug, inside separate 
injector liners. The samples were dried offline, on a hot plate at 60-70 oC for 10 min, and then 
placed on the Linex autosampler tray. The liners were then loaded into the Optic3 PTV inlet, 
where the thermally assisted hydrolysis and methylation (THM) of the lipids was performed in 
helium at 380 oC, following the automated injection of 40 µL methanolic 
tetramethylammonium hydroxide TMAH. Methanolic TMAH (25 %, Acros), purchased from 
Sigma-Aldrich (Gillingham, UK) was diluted to 12.5 % in MeOH (pesticide residue grade,
Distol) from Fisher Scientific (Loughborough, UK) and was used for the online derivatization 
of lipids by THM.
2.8 GC-MS analysis
The methyl mycocerosates, resulting from the transesterification of PDIMs via the 
thermochemolysis process, were separated along the capillary column with a temperature 
program of 50 oC (8 min) to 350 oC (1 min) @ 30 oC/min, and at a carrier gas flow rate of 1.1 
mL of helium per min.
The mass spectrometer was operated to alternatingly collect fragment ions in full scan and 
selected ion monitoring (SIM) modes. Thus, for each analysis run, the instrument generates 
two chromatographic traces: the full mass scan, and the SIM trace. The target compounds 
were detected by collecting the fragment ions m/z 88, 101 (methyl mycocerosates C29/C30, 
and C32) in SIM mode, and the fragment ion m/z 368 extracted from full scan data, for the 
methyl ether of cholesterol. Considering that the PDIMs are expected to be present at trace 
levels, their specific ions were collected in SIM mode, thus reducing the instrumental noise 
by a factor of 10, whereas the much more abundant cholesterol peak was analysed in the full 
scan simultaneous mode, thus keeping the number of diagnostic ions in SIM to the minimum 
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required for the biomarker analytes. Quantitation of both the mycocerosic acid methyl esters, 
and the cholesterol methylated derivative was performed using the integration facility in 
Agilent ChemStation, by manually measuring the areas of the above named peaks in the 
SIM chromatogram for m/z 101, and in full scan for the m/z 368 fragment ions, respectively.
3. RESULTS AND DISCUSSION
Figure 3 shows a summary flowchart of the sputum samples clean up procedure as 
developed and described in the materials and methods section. In essence a multi-step 
protocol was developed aiming to ensure the cleanest sample possible for injection onto the 
GC column.
3.1 Initial methodology
The top line of Figure 3 shows the current methodologies as described in our prior 
publications [14, 15]. The ion chromatograms for m/z 101 and m/z 88 obtained for the methyl 
derivatives of 140 pg of PDIMs standard are shown in Figure 4-a. The doublet peaks can be 
observed, which are characteristic to the coeluting diastereoisomers of methyl
mycocerosates C29 and C30, and to the diastereoisomers of C32, respectively, as discussed in 
our earlier publications [14, 15]. The mass spectra of C29, C30, and C32 are shown in Figures 
4 b-d. Figure 5 shows some examples of the GC-MS traces in full scan and in SIM, 
respectively, for sputum samples with high cholesterol content: (a) a negative sputum, and 
(b) a positive sputum sample extract that saturates the column with both methylated and 
underivatized cholesterol, identified in the NIST library of mass spectra (98% match).
Given the column overloading by abundant sputum matrix background, a pre-injection clean-
up protocol was necessary. Two methods were studied. The first was based around a 
commercial material (Isolute-FL), a synthetic magnesium silicate that is often used for 
commercial clean-up protocols. The second was to use a developed MIP material, designed 
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to absorb cholesterol. As discussed above, cholesterol is a common model target for 
imprinting and a number of papers have developed methodologies. Here we selected an 
acidic based polymer, similar to the work of Puoci [17], which had demonstrated the ability to 
selectively bind the target molecule. Given the nature of the PDIM fragments, we expected 
very little interaction with the polymer, based on the relative charges; however, some non-
specific interactions of the PDIMs may also occur with the MIP material.
3.2 Isolute-FL (Florisil) extraction
Figure 6-a shows the percentage recovery of PDIMs and of cholesterol, using solvent mix A
of dicholoromethane (DCM) and hexane (H), with DCM concentration ranging between 0 -
100 %. The study aimed to identify the optimum solvent mix polarity relative to that of the 
SPE packing, to preferentially extract the PDIMs target analytes, while leaving behind most 
of the cholesterol. Table 1 summarizes the two solvent combinations that we studied, and the 
various concentrations. In this first attempt, the DCM:Hexane mix of solvents at 40 % DCM 
concentration, provided a consistent recovery of 76.4 % for PDIMs with only 6.3 % for 
cholesterol. While in temperate and cold climates this solvent mix can be used for clean-up, 
for the method to be field deployable in countries with high incidence of tuberculosis, hence 
in tropical countries, we further aimed at replacing the highly volatile DCM (b.p. = 39.9 oC) in
a different solvent mix of higher boiling temperatures and also of appropriate polarity.
After testing various less volatile solvents combinations, the preliminary results lead us to 
select the solvent mix B of heptane (Hp) and toluene (To). Figure 6-b presents the results 
obtained after sample clean up through Isolute-FL cartridges with combinations of To and 
Hp. The ideal proportion of these solvents was found to be at 70 % toluene, having provided 
an average recovery of 80.1% for PDIMs and of only 2.05 % for cholesterol, from 50 µL of 
the stock PE solution of standards. When tested on two PE sputum extracts passed through 
commercial Isolute-FL cartridges, this solvent combination resulted in cleaner 
chromatograms, as shown in Figure 7, with recoveries between 38.3 - 68.7 % for PDIMs and 
Page 12 of 31
Ac
ce
pte
d M
an
us
cri
pt
12
only 7.8 – 37.6 % for cholesterol. The poorer efficiency of the clean-up with solvent mix B in 
sputum sample extracts can be due to the matrix complexity and needs to be further 
investigated. While solvent mix A containing DCM lead to some better results (not shown 
here) in certain sputum sample extracts, we aimed for a mix of solvents with higher boiling 
temperatures, that can be used in countries with a high incidence of tuberculosis, and also 
with warmer climate.
3.3 Molecularly imprinted polymer clean-up
Performing the sample clean-up through MIP cartridges as described in the Experimental 
section and schematically presented in Figure 3, is significantly simpler than with the 
commercial SPE, involving less manipulation of solvents and vials. The THM-GC-MS 
analysis of 50 µL aliquots of the 350 µL eluent collected from 500 µL standards solution 
filtered through the MIPs cartridge generated cleaner chromatograms. In the standard stock 
solution, the clean-up resulted in 64.1-70.6% recovery of PDIMs, and 1.7-6.5 % recovery of 
cholesterol. Figure 8 shows an example of overlaying the GC-MS traces obtained from two 
positive sputum sample extracts, by thermochemolysis of 50 µL aliquots, before and after the 
clean up through the MIPs cartridges. The quantitative results indicate that a significant 
amount of the cholesterol background has been removed through the filtration of the sputum 
extracts, with recoveries between 37.5-69.7 % for PDIMs, and of 8.9-14.5 % for cholesterol. 
Based on the above, we believe that further optimization of MIPs cartridges is needed that 
could ensure more efficient filtration of PDIMs and removal of cholesterol via a procedure 
that involves less manipulation of the sample extracts.
These results are very promising for the potential use of SPE clean–up of the PE extracts 
from real sputum samples, prior to their THM-GC-MS analysis. The chromatograms present 
reduced matrix peaks, thus improving the conditions to correctly assign the biomarkers 
signal. One big advantage of using SPE sample clean-up is that this will lead to a lower 
amount of matrix background introduced in the system, less biologic material deposited on 
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the inlet wall, a reduced risk of column overloading and blockage, and hence enabling a 
more robust analytical protocol. This allows the analysis of a greater number of sputum 
samples extracts with a reduced frequency of instrumental interventions for cleaning the inlet 
and the mass spectrometer ion source, and for column trimming. The present proof of 
principle assay can further be developed in a systematic study to evaluate the optimum SPE 
clean-up procedure for an efficient removal of the biological matrix compounds, in order to 
provide a high sensitivity and selectivity of a more robust and reproducible THM-GC-MS 
method for the detection of M. tuberculosis in sputum samples.
4. CONCLUSIONS
In order to ease the identification of the target compound biomarkers for tuberculosis in 
sputum, a proof of principle study was performed of some sample clean-up methods by 
commercial and MIPs solid phase extraction cartridges, aiming to selectively eliminate the 
major matrix compounds from the PE sputum extracts.
When used with the proper solvent combinations, the Isolute-Florisil SPE commercial 
cartridges can remove a high amount of the abundant cholesterol from the sputum extracts, 
while still recovering more than 70 % of the total PDIMs biomarkers present. Though, sample 
manipulation is more complex and requires relatively longer time than the filtering through
MIPs. The MIPs cartridges are relatively easier to use, and the results obtained with 
standards solution show the potential for selective clean-up of sputum sample extracts.
Both clean-up methods demonstrated the potential to remove the cholesterol from the matrix 
background present in the PE sputum extracts, without significant loss of the biomarker 
target analytes. The next step, currently under investigation, is to test this clean-up method to 
a greater number of sputum samples and apply clinically relevant statistics to the study, to 
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further assess the method performance for the whole sample processing, as promised by the 
results obtained in the developed methods presented.
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Tables caption
Table 1.
The combinations and concentrations of solvents tested for the optimisation of the clean-up 
assay aiming to maximizing the recovery of PDIMs and the cholesterol removal from a stock 
solution of standards in PE solvent, through commercial Isolute-Fl (Florisil) SPE cartridges.
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Figures captions
Figure 1: The molecular structure of phthiocerol dimycocerosates (PDIMs), prior to 
thermochemolysis. The dotted lines show the sites of cleavage during the thermally assisted 
hydrolysis and methylation process.
Figure 2: Molecular structures of the target analytes resulted from the transesterification of 
the PDIM moieties [B], [C], and [D] shown in Figure1, via thermally assisted hydrolysis and 
methylation in the PTV inlet.
Figure 3: Flow chart from sputum deposits to the THM-GC-MS analysis of the PE extracts. 
Top: the the sample processing and analysis method without clean-up procedure; Middle: 
protocol for the PE extract clean-up through commercial Isolute-FL SPE cartridges; Bottom: 
filtering of the PE extract through developed MIPs materials.
Figure 4: a) Typical ion chromatograms of the fragment ions at m/z 101 (top trace) and m/z 
88 (lower trace) obtained in SIM mode for 140 pg total PDIMs submitted to 
thermochemolysis with 40 µL methanolic TMAH (12.5 %). b) - d) mass spectra of C29, C30, 
and C32 methyl mycocerosates, obtained in full scan mode for 4.5 ng total PDIMs under
electron impact at 70 eV electron energy.
Figure 5: Examples of the GC-MS traces in full scan (left) and SIM (right) for sputum samples 
with high cholesterol content: a) a negative sputum (N1); and b) a positive sputum (P1). (* = 
the cholesterol derivative peak in full scan).
Figure 6: Recovery of PDIMs and of cholesterol from a standards stock solution in PE, 
following clean up through commercial Isolute-FL SPE cartridges, washed with: a) washing 
mix A (dichloromethane:hexane); and b) washing mix B (toluene:heptane).
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Figure 7: The result of sample clean-up through Isolute-FL commercial SPE cartridges, using 
a concentration of 70 % toluene in a mix with heptane. a) Comparing the full scan plots of 
filtered (black), and non-filtered (grey) PE extract of two positive sputum samples with high 
cholesterol. (* = cholesterol derivative peak). b) Recovery of PDIMs and of cholesterol from 
two positive sputum samples extracts, washed via Isolute-FL SPE cartridge, with 70 % 
toluene in a mix with heptane.
Figure 8: The result of PE sputum sample extracts filtered through MIPs cartridges: a) 
Comparing the plots of the fragment ion m/z 101 extracted from SIM scans for filtered (black) 
and non-filtered (grey) PE extracts of two positive sputum samples (* = cholesterol derivative 
peak). b) Recovery of PDIMs and of cholesterol from two positive sputum PE extracts, 
filtered through MIPs SPE cartridges.
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Table 1. 
Washing 
mix Solvent
Polarity 
index
Boiling 
temp. (oC)
Solvents concentrations 
in the washing mix (%)
DCM 3.1 39.9 30 40 50 60 100A
Hexane 0 68.7 70 60 50 40 -
Toluene 2.4 110.6 30 50 70 75 80 85B
Heptane 0 98.4 70 50 30 25 20 15
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